Attitudes, knowledge and perceptions towards whooping cough and pertussis vaccine in hospitalized adults

被引:6
|
作者
Ridda, Iman [1 ]
Gao, Zhanhai [2 ]
MacIntyre, C. Raina [2 ,3 ]
机构
[1] James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Townsville, Qld 4811, Australia
[2] Univ New S Wales, Fac Med, Sch Publ Hlth & Community Med, Sydney, NSW 2052, Australia
[3] Childrens Hosp, Natl Ctr Immunizat Res & Surveillance Vaccine Pre, Westmead, NSW, Australia
关键词
Whooping cough; Pertussis vaccine; Hospitalized adults; Attitudes; Knowledge; ADOLESCENT; DIPHTHERIA; BARRIERS; TETANUS;
D O I
10.1016/j.vaccine.2013.12.010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Whooping cough or pertussis is a major cause of morbidity and mortality for adults and children around the world. There has been a rise in pertussis-related deaths in the elderly; pertussis vaccination is not currently routinely recommended in adults, excepting new parents and other adults household members including grandparents and care-givers of young children. Currently, there is lack of clear vaccine recommendations after the age of 50 years. Given the increase in adult pertussis, adult vaccine recommendations are a policy consideration. The study surveyed a convenience sample of patients previously recruited in a case control study designed to examine the burden of influenza with and without AMI in adults aged >= 40 years. Our findings showed that only 9.6% had received the pertussis vaccination within the past five years and 79.4% of participants had no knowledge of the pertussis adult booster vaccine, and 30.7% of participants who had regular contact with children under the age of two years in the past 12 months. The results showed that even though there is general acceptance of prevention by vaccines, there is low awareness about pertussis vaccination. This lack of knowledge presents a barrier against pertussis vaccination thus it is imperative that any future adult immunisation policy recommendations around pertussis vaccine include awareness programs in the target population. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1107 / 1112
页数:6
相关论文
共 50 条
  • [21] JMM Profile: Bordetella pertussis and whooping cough (pertussis): still a significant cause of infant morbidity and mortality, but vaccine-preventable
    Fry, Norman K.
    Campbell, Helen
    Amirthalingam, Gayatri
    JOURNAL OF MEDICAL MICROBIOLOGY, 2021, 70 (10)
  • [22] In vitro evaluation of pertussis toxin composite nanofibers as a non-invasive whooping cough vaccine.
    Gawade, T.
    Sawicka, K. M.
    Roemer, E. J.
    Simon, S. R.
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2007, 43 : S33 - S33
  • [23] CHARACTERIZATION OF GENETICALLY INACTIVATED PERTUSSIS TOXIN MUTANTS - CANDIDATES FOR A NEW VACCINE AGAINST WHOOPING-COUGH
    NENCIONI, L
    PIZZA, M
    BUGNOLI, M
    DEMAGISTRIS, T
    DITOMMASO, A
    GIOVANNONI, F
    MANETTI, R
    MARSILI, I
    MATTEUCCI, G
    NUCCI, D
    OLIVIERI, R
    PILERI, P
    PRESENTINI, R
    VILLA, L
    KREEFTENBERG, JG
    SILVESTRI, S
    TAGLIABUE, A
    RAPPUOLI, R
    INFECTION AND IMMUNITY, 1990, 58 (05) : 1308 - 1315
  • [24] Maternal Vaccination With a Monocomponent Pertussis Toxoid Vaccine Is Sufficient to Protect Infants in a Baboon Model of Whooping Cough
    Kapil, Parul
    Papin, James F.
    Wolf, Roman F.
    Zimmerman, Lindsey, I
    Wagner, Leslie D.
    Merkel, Tod J.
    JOURNAL OF INFECTIOUS DISEASES, 2018, 217 (08): : 1231 - 1236
  • [25] Live attenuated B-pertussis as a single-dose nasal vaccine against whooping cough
    Mielcarek, Nathalie
    Debrie, Anne-Sophie
    Raze, Dominique
    Bertout, Julie
    Rouanet, Carine
    Ben Younes, Amena
    Creusy, Colette
    Engle, Jacquelyn
    Goldman, William E.
    Locht, Camille
    PLOS PATHOGENS, 2006, 2 (07) : 662 - 670
  • [26] Knowledge, attitudes, and perceptions towards pneumococcal vaccines among adults in the United States
    Mohanty, Salini
    Tsai, Jui-Hua
    Ning, Ning
    Martinez, Ana
    Verma, Rishi P.
    Chun, Bianca
    Johnson, Kelly D.
    Cossrow, Nicole
    Bailey, M. Doyinsola
    Weiss, Thomas
    Flem, Elmira
    Schmier, Jordana K.
    EXPERT REVIEW OF VACCINES, 2025, 24 (01) : 45 - 52
  • [27] Binding of murine antibodies against whole-cell pertussis vaccine or filamentous haemagglutinin by Bordetella pertussis from patients with whooping cough
    van den Berg, BM
    Beekhuizen, H
    Van Furth, R
    Mooi, FR
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2000, 51 (05) : 530 - 532
  • [28] Diphtheria, pertussis (whooping cough), and tetanus vaccine induced recurrent seizures and acute encephalopathy in a pediatric patient: Possibly due to pertussis fraction
    Patel, Mahendra K.
    Patel, Tejas K.
    Tripathi, C. B.
    JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2012, 3 (01) : 71 - 73
  • [29] IMMUNIZATION AGAINST DIPHTHERIA, PERTUSSIS (WHOOPING-COUGH) AND TETANUS IN CANADA - THE BENEFITS FROM THE USE OF ADSORBED VACCINE
    CAMERON, J
    CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE, 1982, 73 (06): : 404 - 409
  • [30] IMMUNOGLOBULIN-E RESPONSE TO PERTUSSIS TOXIN IN WHOOPING-COUGH AND AFTER IMMUNIZATION WITH A WHOLE-CELL AND AN ACELLULAR PERTUSSIS-VACCINE
    HEDENSKOG, S
    BJORKSTEN, B
    BLENNOW, M
    GRANSTROM, G
    GRANSTROM, M
    INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1989, 89 (2-3): : 156 - 161